Concepedia

Matthew Finnemeyer

MF

Statistics

Publications

3

Citations

244

H-Index

3

Active since

2018

Affiliations

Harvard University(Current)

Clinical Research Institute

University of Illinois Chicago

George Washington University

Matthew Finnemeyer is an author at Harvard University specializing in pharmacotherapy, antimicrobial resistance, and antibiotics.

Top concepts

MedicineAntibioticsDrug SafetyPharmacologyPharmacotherapyPharmacokineticsAntimicrobial Resistance

Publications per year

2018–2019

3

Publications

3

The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)

Thomas P. Lodise, Susan L. Rosenkranz, Matthew Finnemeyer et al. · Clinical Infectious Diseases · 2019 · 151 citations · Full text

Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals

Deverick J. Anderson, Shera Watson, Rebekah W. Moehring et al. · JAMA Network Open · 2019 · 61 citations · Full text

Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants

Eric Wenzler, Susan C Bleasdale, Monica K Sikka et al. · Antimicrobial Agents and Chemotherapy · 2018 · 32 citations · Full text

Drug Safety, Two-period-crossover Study, Oral Fosfomycin Tromethamine +8

1–3 of 3